MIM
Monashee Investment Management Portfolio holdings
AUM
$190M
This Quarter Return
-15.37%
1 Year Return
+42.84%
3 Year Return
+185.9%
5 Year Return
+237.5%
10 Year Return
+2,730.86%
AUM
$275M
AUM Growth
+$275M
(-20%)
Cap. Flow
-$18.1M
Cap. Flow
% of AUM
-6.57%
Top 10 Holdings %
Top 10 Hldgs %
93.23%
Holding
53
New
16
Increased
5
Reduced
4
Closed
26
Top Buys
| 1 |
Vanguard Total Stock Market ETF
VTI
|
$11.2M |
| 2 |
American Tower
AMT
|
$3.83M |
| 3 |
KDNY
Chinook Therapeutics, Inc. Common Stock
KDNY
|
$2.62M |
| 4 |
Xenon Pharmaceuticals
XENE
|
$2.59M |
| 5 |
Arcellx
ACLX
|
$2.21M |
Top Sells
| 1 |
SolarEdge
SEDG
|
$6.45M |
| 2 |
Southwest Gas
SWX
|
$5.87M |
| 3 |
Fulcrum Therapeutics
FULC
|
$5.6M |
| 4 |
Caribou Biosciences
CRBU
|
$4.32M |
| 5 |
KalVista Pharmaceuticals
KALV
|
$3.89M |
Sector Composition
| 1 | Healthcare | 12.43% |
| 2 | Real Estate | 1.96% |
| 3 | Consumer Staples | 1.65% |
| 4 | Materials | 0.96% |
| 5 | Utilities | 0.32% |
| Name | Market Value | Portfolio Weight | Shares or Principal |
Shares Change % | Capital Flow | |
|---|---|---|---|---|---|---|
|
1
Vanguard Total Stock Market ETF
VTI
$526B
| $226M | 82.14% | 1,196,400 +59,300 | +5% | +$11.2M |
|
|
KDNY
2
DELISTED
Chinook Therapeutics, Inc. Common Stock
KDNY
| $4.2M | 1.53% | 240,000 +150,000 | +167% | +$2.62M |
|
|
SLGC
3
DELISTED
SomaLogic, Inc. Class A Common Stock
SLGC
| $4.18M | 1.52% | 925,000 +415,000 | +81% | +$1.88M |
|
4
Hyperfine
HYPR
$97.4M
| $3.89M | 1.41% | 1,742,490 -12,548 | -0.7% | -$28K |
|
|
5
American Tower
AMT
$95.5B
| $3.83M | 1.4% | +15,000 | New | +$3.83M |
|
6
Albertsons Companies
ACI
$10.9B
| $3.34M | 1.22% | 125,000 +65,000 | +108% | +$1.74M |
|
7
Compass Therapeutics
CMPX
$483M
| $3.26M | 1.19% | 1,230,441 -39,770 | -3% | -$105K |
|
8
DocGo
DCGO
$153M
| $2.75M | 1% | 385,058 -24,373 | -6% | -$174K |
|
|
9
Xenon Pharmaceuticals
XENE
$2.98B
| $2.59M | 0.94% | +85,000 | New | +$2.59M |
|
|
VIEW
10
DELISTED
View, Inc. Class A Common Stock
VIEW
| $2.43M | 0.88% | 1,500,000 | – | – |
|
|
11
Arcellx
ACLX
$3.85B
| $2.21M | 0.8% | +122,129 | New | +$2.21M |
|
12
Dyne Therapeutics
DYN
$1.92B
| $2.2M | 0.8% | 319,536 +39,832 | +14% | +$274K |
|
13
AN2 Therapeutics
ANTX
$30.1M
| $1.81M | 0.66% | 233,330 -200,000 | -46% | -$1.55M |
|
14
Crinetics Pharmaceuticals
CRNX
$2.92B
| $1.77M | 0.65% | +95,000 | New | +$1.77M |
|
15
Cytokinetics
CYTK
$4.23B
| $1.77M | 0.64% | +45,000 | New | +$1.77M |
|
16
Gaming and Leisure Properties
GLPI
$13.6B
| $1.56M | 0.57% | +33,908 | New | +$1.56M |
|
17
European Wax Center
EWCZ
$186M
| $1.18M | 0.43% | +67,000 | New | +$1.18M |
|
|
TSVT
18
DELISTED
2seventy bio
TSVT
| $1.06M | 0.38% | +80,000 | New | +$1.06M |
|
19
MoonLake Immunotherapeutics
MLTX
$3.54B
| $1.05M | 0.38% | +200,000 | New | +$1.05M |
|
20
Revelation Biosciences
REVB
$4.69M
| $907K | 0.33% | 817,562 | – | – |
|
21
Eletrobras Common Shares
EBR
$18.5B
| $887K | 0.32% | +100,030 | New | +$887K |
|
22
ProFrac Holding
ACDC
$716M
| $549K | 0.2% | +30,000 | New | +$549K |
|
23
Day One Biopharmaceuticals
DAWN
$769M
| $537K | 0.2% | +30,000 | New | +$537K |
|
24
Lufax Holding
LU
$2.55B
| $510K | 0.19% | +85,000 | New | +$510K |
|
25
Aspen Aerogels
ASPN
$563M
| $371K | 0.14% | +37,500 | New | +$371K |
|